Senti Biosciences (SNTI) Equity Ratio (2021 - 2025)
Senti Biosciences (SNTI) has 5 years of Equity Ratio data on record, last reported at 0.15 in Q3 2025.
- For Q3 2025, Equity Ratio changed N/A year-over-year to 0.15; the TTM value through Sep 2025 reached 0.15, changed N/A, while the annual FY2024 figure was 0.26, 53.19% down from the prior year.
- Equity Ratio reached 0.15 in Q3 2025 per SNTI's latest filing, down from 0.46 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.76 in Q2 2022 and bottomed at 212.07 in Q1 2021.
- Average Equity Ratio over 5 years is 14.98, with a median of 0.36 recorded in 2024.
- Peak YoY movement for Equity Ratio: surged 295.04% in 2022, then tumbled 53.19% in 2024.
- A 5-year view of Equity Ratio shows it stood at 1.15 in 2021, then soared by 161.07% to 0.7 in 2022, then dropped by 20.44% to 0.56 in 2023, then plummeted by 53.19% to 0.26 in 2024, then tumbled by 41.2% to 0.15 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.15 in Q3 2025, 0.46 in Q1 2025, and 0.26 in Q4 2024.